Development of a semi-automated method for tumor budding assessment in colorectal cancer and comparison with manual methods
暂无分享,去创建一个
[1] S. Kakar,et al. Improving tumor budding reporting in colorectal cancer: a Delphi consensus study , 2021, Virchows Archiv.
[2] M. Cui,et al. Artificial intelligence and computational pathology , 2021, Laboratory Investigation.
[3] I. Nagtegaal,et al. Taking tumour budding to the next frontier — a post International Tumour Budding Consensus Conference (ITBCC) 2016 review , 2020, Histopathology.
[4] I. Nagtegaal,et al. Tumour budding in solid cancers , 2020, Nature Reviews Clinical Oncology.
[5] J. A. van der Laak,et al. Assessment of individual tumor buds using keratin immunohistochemistry: moderate interobserver agreement suggests a role for machine learning , 2019, Modern Pathology.
[6] K. Plataniotis,et al. Size and Shape Filtering of Malignant Cell Clusters within Breast Tumors Identifies Scattered Individual Epithelial Cells as the Most Valuable Histomorphological Clue in the Prognosis of Distant Metastasis Risk , 2019, Cancers.
[7] A. Madabhushi,et al. HistoQC: An Open-Source Quality Control Tool for Digital Pathology Slides. , 2019, JCO clinical cancer informatics.
[8] R. Pai,et al. Histopathological Predictors of Recurrence in Stage III Colon Cancer: Reappraisal of Tumor Deposits and Tumor Budding Using AJCC8 Criteria , 2018, International journal of surgical pathology.
[9] S. Kakar,et al. Protocol for the Examination of Resection Specimens From Patients With Primary Carcinoma of the Colon and Rectum , 2019 .
[10] Y. Ishikawa,et al. Immunohistochemical evaluation of tumor budding for stratifying T1 colorectal cancer: optimal cut-off value and a novel computer-assisted semiautomatic method , 2018, Modern Pathology.
[11] K. Mills,et al. The Northern Ireland Biobank: A Cancer Focused Repository of Science , 2018 .
[12] Michael Lippert,et al. Digital image analysis of pan-cytokeratin stained tumor slides for evaluation of tumor budding in pT1/pT2 colorectal cancer: Results of a feasibility study. , 2018, Pathology, research and practice.
[13] R. Riddell,et al. Cytokeratin‐based assessment of tumour budding in colorectal cancer: analysis in stage II patients and prospective diagnostic experience , 2017, The journal of pathology. Clinical research.
[14] Phil Quirke,et al. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016 , 2017, Modern Pathology.
[15] A. Gavin,et al. Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort Study , 2017, Clinical and Translational Gastroenterology.
[16] Peter Bankhead,et al. QuPath: Open source software for digital pathology image analysis , 2017, Scientific Reports.
[17] D. McMillan,et al. The relationship between tumour budding, the tumour microenvironment and survival in patients with primary operable colorectal cancer , 2016, British Journal of Cancer.
[18] Shigehisa Aoki,et al. Cytokeratin immunohistochemistry improves interobserver variability between unskilled pathologists in the evaluation of tumor budding in T1 colorectal cancer , 2016, Pathology international.
[19] F. Offner,et al. Tumor budding in colorectal cancer revisited: results of a multicenter interobserver study , 2015, Virchows Archiv.
[20] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[21] I. Nagtegaal,et al. Predicting lymph node metastasis in pT1 colorectal cancer: a systematic review of risk factors providing rationale for therapy decisions , 2013, Endoscopy.
[22] A. Ruifrok,et al. Quantification of histochemical staining by color deconvolution. , 2001, Analytical and quantitative cytology and histology.